DHDoris Höglinger

Doris Höglinger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Doris Höglinger has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • In Vitro Approaches for Detection of Protein-Lipid Interactions and Protein-to-Protein Transport of Lipids Using Bifunctional Lipid Analogs

    by Denisa Jamecna, Doris Höglinger

    Functionalized lipid analogs are a versatile tool for studying lipid localization, metabolism and interactions in cells. As a common follow-up research, in vitro experiments are utilized to confirm specific interactors and characterize protein-lipid interactions. Here, we describe protocols that rely on commercially available photoactivatable and clickable lipids in reconstituted systems to capture protein-lipid interactions and detect lipid transport between purified proteins.

  • The use of click chemistry in sphingolipid research

    by Denisa Jamecna, Doris Höglinger

    Sphingolipid dysregulation is involved in a range of rare and fatal diseases as well as common pathologies including cancer, infectious diseases or neurodegeneration. Gaining insights into how sphingolipids are involved in these diseases would contribute much to our understanding of human physiology, as well as the pathology mechanisms. However, scientific progress is hampered by a lack of suitable tools that can be used in intact systems. To overcome this, efforts have turned to engineering modified lipids with small clickable tags and to harnessing the power of click chemistry to localize and follow these minimally modified lipid probes in cells. We hope to inspire the readers of this Review to consider applying existing click chemistry tools for their own aspects of sphingolipid research. To this end, we focus here on different biological applications of clickable lipids, mainly to follow metabolic conversions, their visualization by confocal or superresolution microscopy or the identification of their protein interaction partners. Finally, we describe recent approaches employing organelle-targeted and clickable lipid probes to accurately follow intracellular sphingolipid transport with organellar precision.


  • Open Access

    Lysosome-targeted multifunctional lipid probes reveal the sterol transporter NPC1 as a sphingosine interactor

    by Janathan Altuzar, Judith Notbohm, Frank Stein, Per Haberkant, Pia Hempelmann, Saskia Heybrock, Jutta Worsch, Paul Saftig, Doris Höglinger

    Lysosomes are catabolic organelles involved in macromolecular digestion, and their dysfunction is associated with pathologies ranging from lysosomal storage disorders to common neurodegenerative diseases, many of which have lipid accumulation phenotypes. The mechanism of lipid efflux from lysosomes is well understood for cholesterol, while the export of other lipids, particularly sphingosine, is less well studied. To overcome this knowledge gap, we have developed functionalized sphingosine and cholesterol probes that allow us to follow their metabolism, protein interactions, and their subcellular localization. These probes feature a modified cage group for lysosomal targeting and controlled release of the active lipids with high temporal precision. An additional photocrosslinkable group allowed for the discovery of lysosomal interactors for both sphingosine and cholesterol. In this way, we found that two lysosomal cholesterol transporters, NPC1 and to a lesser extent LIMP-2/SCARB2, bind to sphingosine and showed that their absence leads to lysosomal sphingosine accumulation which hints at a sphingosine transport role of both proteins. Furthermore, artificial elevation of lysosomal sphingosine levels impaired cholesterol efflux, consistent with sphingosine and cholesterol sharing a common export mechanism.


  • Faculty Opinions recommendation of MIROs and DRP1 drive mitochondrial-derived vesicle biogenesis and promote quality control.

    by Doris Höglinger

    How does mitochondrial protein quality control work? Aside from the costly option of delivering whole defective mitochondria to lysosomes for degradation (mitophagy), sorting dysfunctional proteins or protein complexes into mitochondrial-derived vesicles (MDVs) for delivery to lysosomes is a more tailored way of repairing damaged proteins or simply remodeling mitochondrial protein content. In this impressive study, König et al. dissect the mechanism of MDV formation via elegant targeted proteomics, lipidomic and live-cell fluorescence approaches. First, they identified the identity of a hundred MDV cargo proteins and showed for some that they are present in MDVs in their assembled state as multi-subunit protein complexes. They went on to thoroughly characterize the mechanisms of MDV biogenesis and found that microtubule-associated motor proteins MIRO1 and MIRO2, phosphatidic acid and, contrary to previous reports, mitochondrial dynamin related protein 1 (DRP1) are required for MDV generation. This newly discovered mechanism will be of particular importance in the study of neurodegenerative disorders but will also boost research into more fundamental questions related to organellar quality control.

  • Open Access

    Lysosome-targeted lipid probes reveal sterol transporters NPC1 and LIMP-2 as sphingosine transporters

    by Janathan Altuzar, Judith Notbohm, Frank Stein, Per Haberkant, Saskia Heybrock, Jutta Worsch, Paul Saftig, Doris Höglinger

    Lysosomes are central catabolic organelles involved in lipid homeostasis and their dysfunction is associated with pathologies ranging from lysosomal storage disorders to common neurodegenerative diseases. The mechanism of lipid efflux from lysosomes is well understood for cholesterol, while the export of other lipids, particularly sphingosine, is less well studied. To overcome this knowledge gap, we have developed functionalized sphingosine and cholesterol probes that allow us to follow their metabolism, protein interactions as well as their subcellular localization. These probes feature a modified cage group for lysosomal targeting and controlled release of the active lipids with high temporal precision. An additional photo-crosslinkable group allowed for the discovery of lysosomal interactors for both sphingosine and cholesterol. In this way, we found that two lysosomal cholesterol transporters, NPC1 and LIMP-2/SCARB2, also directly bind to sphingosine. In addition, we showed that absence of either protein leads to lysosomal sphingosine accumulation which suggests a sphingosine transport role of both proteins. Furthermore, artificial elevation of lysosomal sphingosine levels impaired cholesterol efflux, consistent with sphingosine and cholesterol sharing a common export mechanism.


  • Cellular cholesterol and how to find it

    by Valentin Schoop, Andrea Martello, Emily R. Eden, Doris Höglinger


  • Open Access

    The Glucosylceramide Synthase Inhibitor PDMP Causes Lysosomal Lipid Accumulation and mTOR Inactivation

    by Pia Hartwig, Doris Höglinger

    For many years, the biology of glycosphingolipids was elucidated with the help of glucosylceramide synthase (GCS) inhibitors such as 1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP). Additionally, PDMP gained interest because of its chemosensitizing effects. Several studies have successfully combined PDMP and anti-cancer drugs in the context of cancer therapy. However, the mechanism of action of PDMP is not fully understood and seems to go beyond glycolipid inhibition. Here, we used a functionalized sphingosine analogue (pacSph) to investigate the acute effects of PDMP on cellular sphingolipid distribution and found that PDMP, but not other GCS inhibitors, such as ND-DNJ (also called Miglustat), induced sphingolipid accumulation in lysosomes. This effect could be connected to defective export from lysosome, as monitored by the prolonged lysosomal staining of sphingolipids as well as by a delay in the metabolic conversion of the pacSph precursor. Additionally, other lipids such as lysobisphosphatidic acid (LBPA) and cholesterol were enriched in lysosomes upon PDMP treatment in a time-dependent manner. We could further correlate early LBPA enrichment with dissociation of the mechanistic target of rapamycin (mTOR) from lysosomes followed by nuclear translocation of its downtream target, transcription factor EB (TFEB). Altogether, we report here a timeline of lysosomal lipid accumulation events and mTOR inactivation arising from PDMP treatment.


  • Faculty Opinions recommendation of ORP2 couples LDL-cholesterol transport to FAK activation by endosomal cholesterol/PI(4,5)P2 exchange.

    by Doris Höglinger

    Cholesterol is an essential component of eukaryotic cell membranes, and its uptake and transport between subcellular organelles are highly regulated. A large part of cellular cholesterol stems from uptake of low-density lipoprotein (LDL) particles by receptor-mediated endocytosis. In the acidic environment of late endosomes and lysosomes (LE/LY), cholesterol is released to the limiting membrane by concerted action of two Niemann-Pick C proteins (NPC2 and NPC1) {1,2}. However, mechanisms of post-lysosomal cholesterol transfer are still partly unclear. One way is the direct transport from LE/LY to the endoplasmic reticulum by the actions of sterol transfer proteins such as ORP1L {3}. Another way is transfer to the plasma membrane, where cholesterol serves important structural roles. This thorough study by Takahashi and co-workers marks an important advance in our understanding of how LDL-derived cholesterol reaches the plasma membrane (PM). The authors found that oxysterol-binding protein-related protein 2 (ORP2) is able to transfer cholesterol from late endosomes to focal adhesion kinase (FAK)-containing recycling endosomes in migrating cells and reasoned that cholesterol reaches the PM via that route. Furthermore, they could show that this transfer is associated with a countertransfer of the phospholipid phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) from recycling to late endosomes. Interestingly, FAK itself seems to stimulate the generation of PI(4,5)P2 on recycling endosomes upon association with this compartment, an interaction that is itself dependent on cholesterol. In summary, this study uncovers a novel and interesting crosstalk between ORP2 and FAK in controlling delivery of cholesterol and dynamics of LE/LY organelles.

  • Faculty Opinions recommendation of Structural Basis of Low-pH-Dependent Lysosomal Cholesterol Egress by NPC1 and NPC2.

    by Doris Höglinger

    Lysosomal cholesterol egress requires two proteins, NPC1 and NPC2, whose defects are responsible for Niemann-Pick disease type C (NPC). Here, we present systematic structural characterizations that reveal the molecular basis for low-pH-dependent cholesterol delivery from NPC2 to the transmembrane (TM) domain of NPC1. At pH 8.0, similar structures of NPC1 were obtained in nanodiscs and in detergent at resolutions of 3.6 Å and 3.0 Å, respectively. A tunnel connecting the N-terminal domain (NTD) and the transmembrane sterol-sensing domain (SSD) was unveiled. At pH 5.5, the NTD exhibits two conformations, suggesting the motion for cholesterol delivery to the tunnel. A putative cholesterol molecule is found at the membrane boundary of the tunnel, and TM2 moves toward formation of a surface pocket on the SSD. Finally, the structure of the NPC1-NPC2 complex at 4.0 Å resolution was obtained at pH 5.5, elucidating the molecular basis for cholesterol handoff from NPC2 to NPC1(NTD). Published by Elsevier Inc.

  • Faculty Opinions recommendation of FFAT motif phosphorylation controls formation and lipid transfer function of inter-organelle contacts.

    by Doris Höglinger

    The formation of membrane contact sites (MCSs) between organelles is mainly determined by the interaction between two proteins acting as tethering pairs. MCSs formed with the endoplasmic reticulum (ER) often rely on binding to ER-receptors VAP-A, VAP-B or MOSPD2. A multitude of proteins interacts with these receptors via a seven amino-acid motif called FFAT (two phenylalanines in an acidic tract). Given that many proteins possess such a motif and that they all address the same ER receptors, a long-standing question in the field was how the binding of FFAT-motif-containing proteins to VAPs and MOSPD2 is regulated. Di Mattia et al. uncovered that several VAP/MOSPD2-binding proteins possess a non-canonical FFAT motif they termed Phospho-FFAT. Instead of the classical EFFDAAE core FFAT motif, they showed a related motif featuring an S/T residue at the 4th position replacing the acidic residue. Using pulldown experiments, they showed that the Phospho-FFAT motif is only able to bind to VAPs/MOSPD2 when phosphorylated. Using in silico approaches, the team identified over 100 proteins in the human proteome that featured such a Phospho-FFAT motif, compared to 94 proteins featuring the conventional FFAT motif. In following experiments, the authors used STARD3 as a model protein featuring the novel Phospho-FFAT motif to show that the phosphorylation of the serine (S209) is necessary for the direct interaction of STARD3 with its ER-binding partners in vitro and in vivo. Going further, they showed that phosphorylation is essential for the lipid-transfer activity of STARD3 in vitro and in vivo. Finally, the authors also characterized the structure of the MSP domain of human MOSPD2 with and without interacting peptides and found that MOSPD2 shows overall similarities to VAPs with regards to FFAT binding, however, it also features a second pocket capable of accommodating hydrophobic residues at position +9 in some FFATs. Overall, this elegant study identifies a novel mechanism by which the formation of MCSs can be regulated. Interestingly, most of the identified proteins featuring such a Phospho-FFAT are embedded in the membranes of the partner organelles, meaning that switching off the FFAT motif is the only way for regulating the formation of contacts with the ER. Intriguingly, these results also imply that the formation of MCSs is very likely to occur as a direct consequence of cellular signaling cascades, making the search for the kinases and phosphatases responsible the logical and exciting next step.